Patent details
LUC00247 Product Name: Nimenrix - Vaccin méningococcique conjugué des groupes A, C, W135 et Y
Basic Information
- Publication number:
- LUC00247
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP151893971
- Legal Status:
- Inactive
- Application number:
- LUC00247
- First applicant's nationality:
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 13/06/2023
- SPC Extension Agent Name:
- OFFICE FREYLINGER S.A.
- SPC Extension Status:
- Granted
- SPC Extension Grant Date:
- 21/10/2024
- SPC Extension Rejection Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/12/767
- Marketing Authorization Type:
- Marketing Authorization Date:
- 25/04/2012
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 29/12/2021
- First Marketing Authorization date:
- 25/04/2012
- Grant date:
- 04/10/2024
- Activation date:
- Publication date:
- 29/12/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 25/04/2027
- SPC Extension Expiration:
- 25/10/2027
- Rejection date:
- Withdrawal date:
Owner
- From:
- 29/12/2021
- Name:
- Pfizer Ireland Pharmaceuticals
- Address:
- Operations Support Group, Ringaskiddy Cork, Ireland (IE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 29/12/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/01
- Publication date:
- 03/01/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPCX1
- Bulletin edition number:
- 2023/08
- Publication date:
- 03/07/2023
- Description:
- Section G : Applications for extensions for pediatric use – I1E publication
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/13
- Publication date:
- 05/11/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
4
- Bulletin Heading:
- SPCX2
- Bulletin edition number:
- 2024/13
- Publication date:
- 05/11/2024
- Description:
- Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 19/03/2026
- Last Annual Fee Paid Number:
- 21
- Last Annual Fee Paid Amount:
- 410 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 04/10/2024 | Publication | 1 |
| 04/10/2024 | Certificate | 1 |
| 04/10/2024 | Outgoing Correspondence | 1 |
| 21/10/2024 | Publication | 1 |
| 21/10/2024 | Certificate | 1 |
| 22/10/2024 | Outgoing Correspondence | 1 |
| 05/07/2024 | Outgoing Correspondence | 1 |
| 11/07/2024 | Marketing authorization | 3 |
| 11/07/2024 | Summary of the product caracteristics | 88 |
| 13/06/2023 | Application Form | 3 |
| 13/06/2023 | Marketing authorization | 5 |
| 13/06/2023 | Paediatric investigation plan | 1 |
| 13/06/2023 | Paediatric investigation plan | 11 |
| 13/06/2023 | Summary of the product caracteristics | 56 |
| 13/06/2023 | Publication | 1 |
| 13/06/2023 | FNET_DC_FRONTPAGE | 1 |
| 13/06/2023 | Outgoing Correspondence | 1 |
| 29/12/2021 | MA publication | 11 |
| 29/12/2021 | Publication | 1 |
| 29/12/2021 | Outgoing Correspondence | 1 |
| 29/12/2021 | Summary of the product caracteristics | 56 |
| 29/12/2021 | Application Form | 3 |
| 29/12/2021 | Marketing authorization | 5 |